IA
DGX icon

IndexIQ Advisors’s Quest Diagnostics DGX Stock Holding History

IndexIQ Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$280K Hold
2,041
– – 0.01% 994
2021
Q4 		$353K Sell
2,041
-215
-10% -$32.7K 0.01% 872
2021
Q3 		$328K Buy
2,256
+64
+3% +$9.36K 0.01% 954
2021
Q2 		$289K Buy
2,192
+41
+2% +$5.37K 0.01% 987
2021
Q1 		$276K Buy
2,151
+279
+15% +$34.4K 0.01% 963
2020
Q4 		$223K Buy
1,872
+879
+89% +$107K 0.01% 868
2020
Q3 		$114K Buy
993
+598
+151% +$70.7K ﹤0.01% 907
2020
Q2 		$45K Buy
395
+348
+740% +$36.9K ﹤0.01% 938
2020
Q1 		$4K Sell
47
-1
-2% -$104 ﹤0.01% 900
2019
Q4 		$5K Buy
+48
New +$5.01K ﹤0.01% 718

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

IndexIQ Advisors's DGX Position: Q1 2022 in Review

IndexIQ Advisors held its Quest Diagnostics (DGX) position steady in Q1 2022 at 2,041 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #994.

IndexIQ Advisors first reported a position in DGX in Q4 2019 and has held it in 10 quarters since. The position peaked at $353K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • IndexIQ Advisors held 2,041 shares of Quest Diagnostics worth $280K as of Q1 2022.
  • IndexIQ Advisors left its Quest Diagnostics share count unchanged in Q1 2022.
  • Quest Diagnostics made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #994 holding.
  • IndexIQ Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Quest Diagnostics position peaked at $353K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.